Skip to content

Insider · CIK 0001446125

Greenstreet Yvonne

ceoofficerdirector

Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.). First filing Nov 27, 2024, latest Nov 27, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.3M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
65Notablesell 5ALNY
ALNYLAM PHARMACEUTICALS, INC.
$1.3M5,219-6%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 25, 2024ALNY
ALNYLAM PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+10,658$0.00$084,099Nov 27, 2024
Nov 26, 2024ALNY
ALNYLAM PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-93$247.77$23k84,006Nov 27, 2024
Nov 26, 2024ALNY
ALNYLAM PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-762$249.60$190k83,244Nov 27, 2024
Nov 26, 2024ALNY
ALNYLAM PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,131$250.68$284k82,113Nov 27, 2024
Nov 26, 2024ALNY
ALNYLAM PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-2,933$251.42$737k79,180Nov 27, 2024
Nov 26, 2024ALNY
ALNYLAM PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-300$252.27$76k78,880Nov 27, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.